Official patient Web site for FASLODEX® (fulvestrant) Injection 500 mg, a treatment option for postmenopausal women with hormone receptor-positive metastatic breast cancer.
Official patient Web site for FASLODEX® (fulvestrant) Injection 500 mg, a treatment option for postmenopausal women with hormone receptor-positive metastatic breast cancer after treatment with antiestrogen therapy.
Official patient site for FASLODEX® (fulvestrant) Injection 500 mg, a treatment option for postmenopausal women with hormone receptor-positive metastatic breast cancer after treatment with antiestrogen therapy.